Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Depreciation & Amortization (CF) (2016 - 2025)

National Healthcare Properties (HLTC) has 13 years of Depreciation & Amortization (CF) data on record, last reported at $18.0 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 13.03% year-over-year to $18.0 million; the TTM value through Dec 2025 reached $78.3 million, down 6.91%, while the annual FY2025 figure was $78.3 million, 6.91% down from the prior year.
  • Depreciation & Amortization (CF) reached $18.0 million in Q4 2025 per HLTC's latest filing, roughly flat from $18.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $23.7 million in Q1 2025 and bottomed at $600000.0 in Q4 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $19.3 million, with a median of $20.4 million recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): soared 101.0% in 2021, then decreased 15.46% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $600000.0 in 2021, then soared by 3375.67% to $20.9 million in 2022, then grew by 2.39% to $21.4 million in 2023, then dropped by 3.15% to $20.7 million in 2024, then dropped by 13.03% to $18.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $18.0 million in Q4 2025, $18.0 million in Q3 2025, and $18.5 million in Q2 2025.